The Prostate Cancer Clinical Trials Consortium

The PCCTC is an integrated research organization (IRO) and global clinical consortium formed to address critically unmet needs in prostate cancer. Our mission is to design, implement, and complete innovative process-driven clinical studies, translating scientific discoveries to improved standards of care.

Our Services

The PCCTC is changing how prostate cancer therapies and biomarkers are developed. Our unique infrastructure facilitates project co-development between investigators, clinical research sites, and industry partners.

Our Expertise

Internationally recognized leaders in the field, PCCTC investigators come from the nation’s top academic medical centers where they are actively engaged in world class science through cutting-edge translational prostate cancer research.

Our Participating Clinical Research Sites

The PCCTC is a network of over 200 global clinical research sites